Edison Liu has been elected to the Foundation for the National Institutes of Health's board of directors. His term began on June 19.

Liu is the president and CEO of the Jackson Laboratory and president of the Human Genome Organization. He joined the Jackson Laboratory from the Genome Institute of Singapore, where he was the founding executive director. Prior to that, he was the scientific director of the National Cancer Institute's division of clinical sciences.

Gene synthesis company Gen9 has appointed Kevin Munnelly to be president and CEO and Martin Goldberg to be chief operating officer.

Munnelly previously was general manager in Life Technologies' global next-generation qPCR business, and he was VP and GM of Biotrove, which Life Technologies acquired in 2009. Goldberg spent 17 years at Affymetrix, where he most recently oversaw the company's technology and product development efforts.

23andMe has named Andy Page to its board of directors. He currently serves as president of Gilt Group. Previously he served as chief operating and financial officer at PlayPhone; chief financial officer and senior vice president of business strategy at StubHub; and has held senior executive positions at Panasas, ONI Systems, and Robertson Stephens & Company.

View original post here:
CGC Genetics Rolls out BeadXpress-based Test for Skeletal Dysplasia

Comments are closed.